speb/financial-data huggingface dataset:
DuPont ROE decomposition for CET (annual period ending 2025-12-31)
ROE: 15.796854063773308%
Net margin: 97.21792973773418%
Asset turnover: 0.16217339196452119
Equity multiplier (leverage): 1.001946741353741
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CFW.TO (annual period ending 2022-12-31)
ROE: 2.76070283612154%
Net margin: 0.7788716799402357%
Asset turnover: 1.5056143441194754
Equity multiplier (leverage): 2.3541818370955996
EBIT margin: 6.163671775990182%
Interest burden factor: 0.2627506574177281
Tax burden factor: 0.48093080724876447
ROE archetype: Low Return
DuPont ROE decomposition for CFW.TO (annual period ending 2023-12-31)
ROE: 37.15229226650859%
Net margin: 10.22764272124213%
Asset turnover: 1.781730616912896
Equity multiplier (leverage): 2.038769007900506
EBIT margin: 11.130940024599296%
Interest burden factor: 0.9716450133004357
Tax burden factor: 0.9456623088063166
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CFW.TO (annual period ending 2024-12-31)
ROE: 1.5723653235288941%
Net margin: 0.6623361544183601%
Asset turnover: 1.277029989265289
Equity multiplier (leverage): 1.8589764972503107
EBIT margin: 2.9132072967983045%
Interest burden factor: 0.11059039943938331
Tax burden factor: 2.055841584158416
ROE archetype: Low Return
DuPont ROE decomposition for CFW.TO (annual period ending 2025-12-31)
ROE: 4.691998276166595%
Net margin: 2.1807969116664854%
Asset turnover: 1.2446559648432745
Equity multiplier (leverage): 1.7285951719819004
EBIT margin: 6.473223131087741%
Interest burden factor: 0.734061261742576
Tax burden factor: 0.4589467938317842
ROE archetype: Low Return
DuPont ROE decomposition for CFX.L (quarterly period ending 2024-10-31)
Equity multiplier (leverage): 2.459944151411728
ROE archetype: Standard Business
DuPont ROE decomposition for CFX.L (quarterly period ending 2025-04-30)
Equity multiplier (leverage): 2.346581438136015
ROE archetype: Standard Business
DuPont ROE decomposition for CFX.L (quarterly period ending 2025-10-31)
Equity multiplier (leverage): 2.271991446465453
ROE archetype: Standard Business
DuPont ROE decomposition for CGD.V (annual period ending 2022-12-31)
ROE: 18.56144867792854%
Asset turnover: 0
Equity multiplier (leverage): 1.3810379293955801
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CGD.V (annual period ending 2023-12-31)
ROE: 18.79881999433998%
Asset turnover: 0
Equity multiplier (leverage): 1.1335648443683337
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CGD.V (annual period ending 2024-12-31)
ROE: -3.789195896510015%
Asset turnover: 0
Equity multiplier (leverage): 1.0085135084181318
ROE archetype: Low Return
DuPont ROE decomposition for CGD.V (annual period ending 2025-12-31)
ROE: 21.620168059432%
Asset turnover: 0
Equity multiplier (leverage): 1.0092529665839916
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CGG.TO (quarterly period ending 2025-03-31)
ROE: 4.578889571747955%
Net margin: 31.483068225093007%
Asset turnover: 0.08999317874007703
Equity multiplier (leverage): 1.6161197107565215
EBIT margin: 36.958798371268706%
Interest burden factor: 0.9488472551098254
Tax burden factor: 0.897765479795343
ROE archetype: Low Return
DuPont ROE decomposition for CGG.TO (quarterly period ending 2025-06-30)
ROE: 6.156015093844441%
Net margin: 37.86356580065024%
Asset turnover: 0.10214411478054344
Equity multiplier (leverage): 1.5917131922162027
EBIT margin: 45.92100081687381%
Interest burden factor: 0.9868959114393236
Tax burden factor: 0.8354853072128228
ROE archetype: Standard Business
DuPont ROE decomposition for CGG.TO (quarterly period ending 2025-09-30)
ROE: 6.752400166231235%
Net margin: 41.241529623854426%
Asset turnover: 0.10738143468719
Equity multiplier (leverage): 1.524734422716571
EBIT margin: 50.10607896216517%
Interest burden factor: 0.8876150371068783
Tax burden factor: 0.9272987943955685
ROE archetype: Standard Business
DuPont ROE decomposition for CGG.TO (quarterly period ending 2025-12-31)
ROE: 5.662765019206257%
Net margin: 33.19150374024651%
Asset turnover: 0.11691965274132297
Equity multiplier (leverage): 1.4591975616042352
EBIT margin: 43.29900658636877%
Interest burden factor: 1.0306568379095482
Tax burden factor: 0.7437635780142463
ROE archetype: Standard Business
DuPont ROE decomposition for CGG.TO (quarterly period ending 2026-03-31)
ROE: 9.944662004174871%
Net margin: 52.15565651595422%
Asset turnover: 0.12978820829222332
Equity multiplier (leverage): 1.4691068152246332
EBIT margin: 59.93362797686687%
Interest burden factor: 0.9837751867491835
Tax burden factor: 0.8845756584610087
ROE archetype: Standard Business
DuPont ROE decomposition for CGL.L (annual period ending 2022-12-31)
ROE: -24.700005868174717%
Asset turnover: -0.23464155485749713
Equity multiplier (leverage): 1.0189991574460255
ROE archetype: Low Return
DuPont ROE decomposition for CGL.L (annual period ending 2023-12-31)
ROE: -4.288312328351655%
Asset turnover: -0.004269416488725771
Equity multiplier (leverage): 1.1687332754173418
ROE archetype: Low Return
DuPont ROE decomposition for CGL.L (annual period ending 2024-12-31)
ROE: 29.72193363566901%
Net margin: 97.39481415688807%
Asset turnover: 0.2430029825753844
Equity multiplier (leverage): 1.255826441217963
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CGL.L (annual period ending 2025-12-31)
ROE: 13.755662104766934%
Net margin: 84.87987549651322%
Asset turnover: 0.12754490396071405
Equity multiplier (leverage): 1.2706140528006638
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CGO (quarterly period ending 2024-10-31)
Equity multiplier (leverage): 1.5482933997129242
ROE archetype: Standard Business
DuPont ROE decomposition for CGO (quarterly period ending 2025-04-30)
Equity multiplier (leverage): 1.5149462910407057
ROE archetype: Standard Business
DuPont ROE decomposition for CGO (quarterly period ending 2025-10-31)
Equity multiplier (leverage): 1.466123638222408
ROE archetype: Standard Business
DuPont ROE decomposition for CGO.TO (annual period ending 2022-08-31)
ROE: 14.000708974088798%
Net margin: 15.283912051103634%
Asset turnover: 0.3163291182691216
Equity multiplier (leverage): 2.895851767526234
EBIT margin: 26.042800496291836%
Interest burden factor: 0.7116059924229311
Tax burden factor: 0.8247213724366804
ROE archetype: Standard Business
DuPont ROE decomposition for CGO.TO (annual period ending 2023-08-31)
ROE: 10.282136804909385%
Net margin: 11.367073702686282%
Asset turnover: 0.3139706758626157
Equity multiplier (leverage): 2.881015628116642
EBIT margin: 26.219842291933887%
Interest burden factor: 0.5305488884955358
Tax burden factor: 0.8171338313727503
ROE archetype: Standard Business
DuPont ROE decomposition for CGO.TO (annual period ending 2024-08-31)
ROE: 10.239759390668942%
Net margin: 11.365735356548583%
Asset turnover: 0.31297704988368424
Equity multiplier (leverage): 2.878589386178914
EBIT margin: 25.25672701721056%
Interest burden factor: 0.5296179229972642
Tax burden factor: 0.8496846948726741
ROE archetype: Standard Business
DuPont ROE decomposition for CGO.TO (annual period ending 2025-08-31)
ROE: 9.543115769427573%
Net margin: 11.14207933842647%
Asset turnover: 0.3053135026601644
Equity multiplier (leverage): 2.8052911017372666
EBIT margin: 24.36640259087045%
Interest burden factor: 0.5767116073596866
Tax burden factor: 0.7928958387547018
ROE archetype: Standard Business
DuPont ROE decomposition for CGY.TO (quarterly period ending 2025-03-31)
ROE: 0.09166586394299939%
Net margin: 0.1523233178600381%
Asset turnover: 0.2498245641192345
Equity multiplier (leverage): 2.4088297531857776
EBIT margin: 2.5667769934991504%
Interest burden factor: 0.023134178233755784
Tax burden factor: 2.565217391304348
ROE archetype: Low Return
DuPont ROE decomposition for CGY.TO (quarterly period ending 2025-06-30)
ROE: 0.19357812097799695%
Net margin: 0.3069463520206434%
Asset turnover: 0.26218263069574105
Equity multiplier (leverage): 2.4054142357262984
EBIT margin: 3.1090023723311275%
Interest burden factor: 0.2556894243641232
Tax burden factor: 0.3861256544502617
ROE archetype: Low Return
DuPont ROE decomposition for CGY.TO (quarterly period ending 2025-09-30)
ROE: 6.586978484628619%
Net margin: 10.16236754420935%
Asset turnover: 0.2791612425172814
Equity multiplier (leverage): 2.321861039328679
EBIT margin: 5.461632731406971%
Interest burden factor: 2.1158871767144274
Tax burden factor: 0.8793867120954002
ROE archetype: Standard Business
DuPont ROE decomposition for CGY.TO (quarterly period ending 2025-12-31)
ROE: 1.596176312391433%
Net margin: 2.4504807692307695%
Asset turnover: 0.28461361585159234
Equity multiplier (leverage): 2.2886210602731087
EBIT margin: 5.191346153846154%
Interest burden factor: 0.6616966104834229
Tax burden factor: 0.7133659902029391
ROE archetype: Low Return
DuPont ROE decomposition for CGY.TO (quarterly period ending 2026-03-31)
ROE: 2.0373747439080154%
Net margin: 2.9361480710622168%
Asset turnover: 0.28154149989322697
Equity multiplier (leverage): 2.464623271038255
EBIT margin: 6.521178307047193%
Interest burden factor: 0.649188681775513
Tax burden factor: 0.6935550506093783
ROE archetype: Low Return
DuPont ROE decomposition for CHA (quarterly period ending 2024-12-31)
ROE: 23.925503045044884%
Net margin: 19.764181301369412%
Asset turnover: 0.5055143140513509
Equity multiplier (leverage): 2.3946871908439906
EBIT margin: 19.268173892598007%
Interest burden factor: 1.0930468199158576
Tax burden factor: 0.9384248658624107
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CHA (quarterly period ending 2025-03-31)
ROE: 18.981073569283975%
Net margin: 20.009308190411737%
Asset turnover: 0.49122759174156927
Equity multiplier (leverage): 1.9311052580712167
EBIT margin: 24.192334684563463%
Interest burden factor: 1.018625057262883
Tax burden factor: 0.8119699113583545
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CHA (quarterly period ending 2025-06-30)
ROE: 1.23043545226682%
Net margin: 2.3181500179628265%
Asset turnover: 0.3655301548583188
Equity multiplier (leverage): 1.4520918494483328
EBIT margin: 3.229827235726606%
Interest burden factor: 1.8923281357444202
Tax burden factor: 0.37928511449069685
ROE archetype: Low Return
DuPont ROE decomposition for CHA (quarterly period ending 2025-09-30)
ROE: 4.736198645753312%
Net margin: 12.40068820850723%
Asset turnover: 0.2803062072637135
Equity multiplier (leverage): 1.3625467306773986
EBIT margin: 14.163006922604596%
Interest burden factor: 1.1143297916354897
Tax burden factor: 0.7857358688804318
ROE archetype: Low Return
DuPont ROE decomposition for CHA (quarterly period ending 2025-12-31)
ROE: 0.42173120861163865%
Net margin: 1.140869764009568%
Asset turnover: 0.2568186405094652
Equity multiplier (leverage): 1.439372256353344
EBIT margin: -1.1951312580160935%
Tax burden factor: 0.47109044214617896
ROE archetype: Low Return
DuPont ROE decomposition for CHA (quarterly period ending 2026-03-31)
ROE: 5.796912592378152%
Net margin: 12.699601607557359%
Asset turnover: 0.3087782856672642
Equity multiplier (leverage): 1.478290898860075
EBIT margin: 15.430283296592417%
Interest burden factor: 1.0379689230533045
Tax burden factor: 0.7929245175047056
ROE archetype: Standard Business
DuPont ROE decomposition for CHD (annual period ending 2022-12-31)
ROE: 11.859938680191409%
Net margin: 7.699605625418558%
Asset turnover: 0.6441238496932515
Equity multiplier (leverage): 2.391357918565002
EBIT margin: 18.766277252771786%
Interest burden factor: 0.518735130848533
Tax burden factor: 0.7909420982228167
ROE archetype: Standard Business
DuPont ROE decomposition for CHD (annual period ending 2023-12-31)
ROE: 20.573700189236654%
Net margin: 12.876838391928969%
Asset turnover: 0.6938184311963488
Equity multiplier (leverage): 2.3028058758662002
EBIT margin: 18.020075325073705%
Interest burden factor: 0.91488556837526
Tax burden factor: 0.7810626421335538
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CHD (annual period ending 2024-12-31)
ROE: 14.247462330517758%
Net margin: 9.583926904750209%
Asset turnover: 0.6998619093185425
Equity multiplier (leverage): 2.1241328107884425
EBIT margin: 19.063057752452064%
Interest burden factor: 0.6496306476550421
Tax burden factor: 0.7738992463308211
ROE archetype: Standard Business
DuPont ROE decomposition for CHD (annual period ending 2025-12-31)
ROE: 17.620471122802822%
Net margin: 11.877740521021408%
Asset turnover: 0.6971650136270405
Equity multiplier (leverage): 2.1278847303599187
EBIT margin: 17.37167913335053%
Interest burden factor: 0.8879918337045286
Tax burden factor: 0.7699864144633713
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CHDN (annual period ending 2022-12-31)
ROE: 79.67361740707162%
Net margin: 24.278925848160018%
Asset turnover: 0.2915834246310498
Equity multiplier (leverage): 11.254397098821396
EBIT margin: 22.22345010498398%
Interest burden factor: 1.513674788662357
Tax burden factor: 0.7217477003942181
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CHDN (annual period ending 2023-12-31)
ROE: 57.75378866514428%
Net margin: 16.951700044684568%
Asset turnover: 0.3740531669996885
Equity multiplier (leverage): 9.1082278043042
EBIT margin: 24.105293090140957%
Interest burden factor: 0.946747556454331
Tax burden factor: 0.7427910288358847
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CHDN (annual period ending 2024-12-31)
ROE: 42.97661375131454%
Net margin: 15.693230442892148%
Asset turnover: 0.38426296780358926
Equity multiplier (leverage): 7.126746457008363
EBIT margin: 25.629960136049444%
Interest burden factor: 0.8179223744292238
Tax burden factor: 0.7486043265875785
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CHDN (annual period ending 2025-12-31)
ROE: 35.70932332916493%
Net margin: 13.175433200041011%
Asset turnover: 0.3964526706593317
Equity multiplier (leverage): 6.836367004770506
EBIT margin: 25.168324276291052%
Interest burden factor: 0.7229766431287343
Tax burden factor: 0.7240796393688955
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CHENNPETRO.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 2.2952000259142884
ROE archetype: Standard Business
DuPont ROE decomposition for CHENNPETRO.NS (quarterly period ending 2024-12-31)
Net margin: 0.16076921648603984%
EBIT margin: 0.6877177889049125%
Interest burden factor: 0.2749465631679604
Tax burden factor: 0.8502454991816693
ROE archetype: Standard Business
DuPont ROE decomposition for CHENNPETRO.NS (quarterly period ending 2025-03-31)
ROE: 5.726209842018363%
Net margin: 2.724370866455796%
Asset turnover: 1.0107899272135525
Equity multiplier (leverage): 2.0794099906782915
EBIT margin: 3.6823907538471525%
Interest burden factor: 0.947259044680248
Tax burden factor: 0.7810297832735009
ROE archetype: Standard Business
DuPont ROE decomposition for CHENNPETRO.NS (quarterly period ending 2025-06-30)
Net margin: -0.2707222342618228%
EBIT margin: -0.3528840694480169%
ROE archetype: Standard Business
DuPont ROE decomposition for CHENNPETRO.NS (quarterly period ending 2025-12-31)
Net margin: 6.386400198429272%
EBIT margin: 8.420937858863994%
Interest burden factor: 1.0081246639963048
Tax burden factor: 0.752283310800661
ROE archetype: Standard Business
DuPont ROE decomposition for CHENNPETRO.NS (quarterly period ending 2026-03-31)
ROE: 12.798839881503726%
Net margin: 8.454676488287076%
Asset turnover: 0.8394129761383046
Equity multiplier (leverage): 1.803424365909007
EBIT margin: 11.214569265495333%
Interest burden factor: 1.0140827894103361
Tax burden factor: 0.7434315442733525
ROE archetype: Standard Business
DuPont ROE decomposition for CHENNPETRO.NS (quarterly period ending 2026-06-30)
Net margin: 3.7682773417047657%
EBIT margin: 5.11522594501059%
Interest burden factor: 0.9858857142857141
Tax burden factor: 0.7472251202689388
ROE archetype: Standard Business
DuPont ROE decomposition for CHH.L (annual period ending 2022-12-31)
ROE: 13.93694393447253%
Net margin: 9.566450174486233%
Asset turnover: 1.087698025674144
Equity multiplier (leverage): 1.3393941533681684
EBIT margin: 11.740257851880573%
Interest burden factor: 0.9909175353493652
Tax burden factor: 0.8223101760233309
ROE archetype: Standard Business
DuPont ROE decomposition for CHH.L (annual period ending 2023-12-31)
ROE: 13.5553652028852%
Net margin: 9.372229441698344%
Asset turnover: 1.0779654338716005
Equity multiplier (leverage): 1.3417248879532333
EBIT margin: 12.450964913346047%
Interest burden factor: 1.0522824814670309
Tax burden factor: 0.7153318502039303
ROE archetype: Standard Business
DuPont ROE decomposition for CHH.L (annual period ending 2024-12-31)
ROE: 10.437613394503014%
Net margin: 8.131171834080659%
Asset turnover: 0.9743306385801652
Equity multiplier (leverage): 1.3174729531958143
EBIT margin: 10.21346721342889%
Interest burden factor: 1.0676672920575359
Tax burden factor: 0.7456654170571696
ROE archetype: Standard Business
DuPont ROE decomposition for CHH.L (annual period ending 2025-12-31)
ROE: 7.37856447498684%
Net margin: 5.717319768737628%
Asset turnover: 0.9937754676786342
Equity multiplier (leverage): 1.2986470164378632
EBIT margin: 7.398036105247978%
Interest burden factor: 1.0680489101541732
Tax burden factor: 0.7235772357723578
ROE archetype: Standard Business
DuPont ROE decomposition for CHL.AX (annual period ending 2021-06-30)
ROE: -14.65678193098457%
Net margin: -24.398427763397564%
Asset turnover: 0.2766670215130092
Equity multiplier (leverage): 2.17129779017232
EBIT margin: -27.019775659223118%
ROE archetype: Low Return
DuPont ROE decomposition for CHL.AX (annual period ending 2022-06-30)
ROE: -65.04893958910941%
Net margin: -76.32032257497627%
Asset turnover: 0.3055954035168024
Equity multiplier (leverage): 2.789030131444465
EBIT margin: -117.69719448161678%
ROE archetype: Low Return
DuPont ROE decomposition for CHL.AX (annual period ending 2023-06-30)
ROE: -9.474262435607534%
Net margin: -14.889361734959897%
Asset turnover: 0.31934821027866916
Equity multiplier (leverage): 1.992529879501226
EBIT margin: -62.10968107976144%
ROE archetype: Low Return
DuPont ROE decomposition for CHL.AX (annual period ending 2024-06-30)
ROE: -13.070293475879039%
Net margin: -17.002706823688982%
Asset turnover: 0.4537590660842285
Equity multiplier (leverage): 1.6941113710533349
EBIT margin: -17.56242880051861%
ROE archetype: Low Return
DuPont ROE decomposition for CHPG (quarterly period ending 2025-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CHPG (quarterly period ending 2025-06-30)
ROE: -0.19022556498161752%
Asset turnover: 0
Equity multiplier (leverage): 1.0353261929505402
ROE archetype: Low Return
DuPont ROE decomposition for CHPG (quarterly period ending 2025-09-30)
ROE: 0.9181875893601785%
Asset turnover: 0
Equity multiplier (leverage): 1.0239060123262156
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CHPG (quarterly period ending 2025-12-31)
ROE: 0.9074468489701948%
Asset turnover: 0
Equity multiplier (leverage): 1.021885879354122
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CHPG (quarterly period ending 2026-03-31)
ROE: 0.7556260396850665%
Asset turnover: 0
Equity multiplier (leverage): 1.0225439588096856
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CHRN (annual period ending 2025-05-31)
ROE: -95.50635570963337%
Net margin: -86.19749691855503%
Asset turnover: 0.27737015121630504
Equity multiplier (leverage): 3.994642294358651
EBIT margin: -68.29430169716507%
ROE archetype: Low Return
DuPont ROE decomposition for CHRW (quarterly period ending 2025-03-31)
ROE: 7.799622418538961%
Net margin: 3.3434814196118356%
Asset turnover: 0.77433060204963
Equity multiplier (leverage): 3.012646961333929
EBIT margin: 4.370258529087611%
Interest burden factor: 0.8866233538588545
Tax burden factor: 0.8628844019846685
ROE archetype: Standard Business
DuPont ROE decomposition for CHRW (quarterly period ending 2025-06-30)
ROE: 8.665311021644097%
Net margin: 3.685952255301105%
Asset turnover: 0.7843255964979226
Equity multiplier (leverage): 2.9973541620727047
EBIT margin: 5.219793436209898%
Interest burden factor: 0.8979895238492213
Tax burden factor: 0.7863667074107884
ROE archetype: Standard Business
DuPont ROE decomposition for CHRW (quarterly period ending 2025-09-30)
ROE: 8.951817803345282%
Net margin: 3.9398856036700423%
Asset turnover: 0.7842536776885551
Equity multiplier (leverage): 2.8971505134798767
EBIT margin: 5.338269783308347%
Interest burden factor: 0.9293502870908729
Tax burden factor: 0.7941520410848105
ROE archetype: Standard Business
DuPont ROE decomposition for CHRW (quarterly period ending 2025-12-31)
ROE: 7.363353326016127%
Net margin: 3.4841234830551486%
Asset turnover: 0.7607514314032296
Equity multiplier (leverage): 2.7780453011433854
EBIT margin: 4.635061700123242%
Interest burden factor: 0.9182533511990427
Tax burden factor: 0.8186070810914681
ROE archetype: Standard Business
DuPont ROE decomposition for CHRW (quarterly period ending 2026-03-31)
ROE: 8.295359020645856%
Net margin: 3.668961413270191%
Asset turnover: 0.7796798072626241
Equity multiplier (leverage): 2.8998514832518634
EBIT margin: 4.377993757186139%
Interest burden factor: 0.9486982457338661
Tax burden factor: 0.8833644321515782
ROE archetype: Standard Business
DuPont ROE decomposition for CIA.AX (annual period ending 2023-03-31)
ROE: 15.895015775668728%
Net margin: 14.108790658014703%
Asset turnover: 0.6144283882348013
Equity multiplier (leverage): 1.8335801581368238
EBIT margin: 26.041374501165855%
Interest burden factor: 0.9354552227524996
Tax burden factor: 0.5791657649078764
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIA.AX (annual period ending 2024-03-31)
ROE: 17.391849416536147%
Net margin: 14.779662856749775%
Asset turnover: 0.6254418227353256
Equity multiplier (leverage): 1.88145710081943
EBIT margin: 27.005349787226525%
Interest burden factor: 0.918006697623115
Tax burden factor: 0.5961682878213564
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIA.AX (annual period ending 2025-03-31)
ROE: 9.841433039056941%
Net margin: 8.803003476084797%
Asset turnover: 0.5540033609206565
Equity multiplier (leverage): 2.017971689344422
EBIT margin: 19.756729840226523%
Interest burden factor: 0.8317189156634066
Tax burden factor: 0.5357216940037036
ROE archetype: Standard Business
DuPont ROE decomposition for CIA.AX (annual period ending 2026-03-31)
ROE: 11.831585241219948%
Net margin: 9.53455638173259%
Asset turnover: 0.5636346518420821
Equity multiplier (leverage): 2.201632159307423
EBIT margin: 17.435587668408363%
Interest burden factor: 0.9230497499700224
Tax burden factor: 0.592432386884302
ROE archetype: Standard Business
DuPont ROE decomposition for CIB (quarterly period ending 2025-03-31)
ROE: 4.233187455646311%
Net margin: 26.482325183490392%
Asset turnover: 0.01830131770213579
Equity multiplier (leverage): 8.734318532439046
Tax burden factor: 0.754065207396507
ROE archetype: Low Return
DuPont ROE decomposition for CIB (quarterly period ending 2025-06-30)
ROE: 4.39862035797884%
Net margin: 25.54928034534595%
Asset turnover: 0.019574832050237582
Equity multiplier (leverage): 8.795079382111023
Tax burden factor: 0.7362918458805892
ROE archetype: Low Return
DuPont ROE decomposition for CIB (quarterly period ending 2025-09-30)
ROE: 5.088595312524804%
Net margin: 29.36217726572702%
Asset turnover: 0.01987373687999156
Equity multiplier (leverage): 8.720273809167386
Tax burden factor: 0.7189967843429108
ROE archetype: Standard Business
DuPont ROE decomposition for CIB (quarterly period ending 2025-12-31)
ROE: -2.3531851217660957%
Net margin: -16.058715105168844%
Asset turnover: 0.016416106299922753
Equity multiplier (leverage): 8.926375350151224
Tax burden factor: -0.5361866678142237
ROE archetype: Low Return
DuPont ROE decomposition for CIB (quarterly period ending 2026-03-31)
ROE: 3.8149794594560684%
Net margin: 20.100053933674968%
Asset turnover: 0.019395649924726154
Equity multiplier (leverage): 9.785671764604759
Tax burden factor: 0.6926005960765595
ROE archetype: Low Return
DuPont ROE decomposition for CIGI (quarterly period ending 2025-03-31)
ROE: 0.3569770234568889%
Net margin: 0.7814786578686787%
Asset turnover: 0.1866943563554314
Equity multiplier (leverage): 2.446763269554079
EBIT margin: 3.591489436280309%
Interest burden factor: 0.33256069293644014
Tax burden factor: 0.6542920029347029
ROE archetype: Low Return
DuPont ROE decomposition for CIGI (quarterly period ending 2025-06-30)
ROE: 2.591408605898064%
Net margin: 4.746859159914785%
Asset turnover: 0.21883386493368398
Equity multiplier (leverage): 2.494681001624415
EBIT margin: 8.551336438494001%
Interest burden factor: 0.7741535204179032
Tax burden factor: 0.7170430981337219
ROE archetype: Low Return
DuPont ROE decomposition for CIGI (quarterly period ending 2025-09-30)
ROE: 2.4578313871585933%
Net margin: 4.451786551550203%
Asset turnover: 0.21901755810973433
Equity multiplier (leverage): 2.5208024962191726
EBIT margin: 7.104103757916421%
Interest burden factor: 0.8106022705406966
Tax burden factor: 0.7730671540817053
ROE archetype: Low Return
DuPont ROE decomposition for CIGI (quarterly period ending 2025-12-31)
ROE: 3.1467927566456666%
Net margin: 5.386092515304583%
Asset turnover: 0.238074064400297
Equity multiplier (leverage): 2.4540434432754945
EBIT margin: 8.798944318397554%
Interest burden factor: 0.8319809845853466
Tax burden factor: 0.7357492687572273
ROE archetype: Low Return
DuPont ROE decomposition for CIGI (quarterly period ending 2026-03-31)
ROE: 0.38005101179510237%
Net margin: 0.8206493933635434%
Asset turnover: 0.1901944771279019
Equity multiplier (leverage): 2.4349292040230015
EBIT margin: 3.874387881888613%
Interest burden factor: 0.37414765469944383
Tax burden factor: 0.5661239495798319
ROE archetype: Low Return
DuPont ROE decomposition for CIIT (annual period ending 2021-07-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CIIT (annual period ending 2022-07-31)
Net margin: 21.274933950021186%
Asset turnover: 1.9341383358819209
EBIT margin: 25.479020082647153%
Interest burden factor: 1
Tax burden factor: 0.8349981232014013
ROE archetype: Standard Business
DuPont ROE decomposition for CIIT (annual period ending 2023-07-31)
Net margin: -75.42069233812767%
Asset turnover: 0.841143381713104
EBIT margin: -76.03606471135632%
ROE archetype: Standard Business
DuPont ROE decomposition for CIIT (annual period ending 2024-07-31)
ROE: 43.176326454164354%
Net margin: 1.2802205804277809%
Asset turnover: 13.982534740493726
Equity multiplier (leverage): 2.4119870804189887
EBIT margin: 1.9530906848054457%
Interest burden factor: 0.8688258676315931
Tax burden factor: 0.7544485932734262
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIM (quarterly period ending 2025-03-31)
ROE: 6.327267418640396%
Net margin: 84.94389438943895%
Asset turnover: 0.0149144367961836
Equity multiplier (leverage): 4.994329184164982
Tax burden factor: 0.9896185788988003
ROE archetype: Standard Business
DuPont ROE decomposition for CIM (quarterly period ending 2025-06-30)
ROE: 1.3457098144761555%
Net margin: 59.00269631503612%
Asset turnover: 0.004281089639277832
Equity multiplier (leverage): 5.327521853549191
Tax burden factor: 0.9885942162358125
ROE archetype: Low Return
DuPont ROE decomposition for CIM (quarterly period ending 2025-09-30)
ROE: -0.022325857827782566%
Net margin: -1.714505306098318%
Asset turnover: 0.002256867236911084
Equity multiplier (leverage): 5.769833878295975
ROE archetype: Low Return
DuPont ROE decomposition for CIM (quarterly period ending 2025-12-31)
ROE: 1.1015697719176691%
Net margin: 42.93898335909794%
Asset turnover: 0.004267360047460815
Equity multiplier (leverage): 6.01175073854009
Tax burden factor: 1.0052512063582175
ROE archetype: Low Return
DuPont ROE decomposition for CIM (quarterly period ending 2026-03-31)
ROE: -1.7436874721157927%
Net margin: -99.0726743530155%
Asset turnover: 0.0027885434848035516
Equity multiplier (leverage): 6.311569074505411
ROE archetype: Low Return
DuPont ROE decomposition for CINELINE.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 4.049274966523994
ROE archetype: Standard Business
DuPont ROE decomposition for CINELINE.NS (quarterly period ending 2025-03-31)
ROE: -39.14584503517391%
Net margin: -101.8188825643608%
Asset turnover: 0.1232005690221104
Equity multiplier (leverage): 3.120646908655608
EBIT margin: 3.4014285636372557%
Interest burden factor: -39.48417958311064
ROE archetype: Low Return
DuPont ROE decomposition for CINELINE.NS (quarterly period ending 2025-06-30)
Net margin: -4.545835927736489%
EBIT margin: -2.5564255086134184%
ROE archetype: Standard Business
DuPont ROE decomposition for CINELINE.NS (quarterly period ending 2025-09-30)
ROE: 2.7883521582186077%
Net margin: 6.530070207653941%
Asset turnover: 0.20331073424827587
Equity multiplier (leverage): 2.10024260021125
EBIT margin: 9.477629882546195%
Interest burden factor: 0.8530713701988558
Tax burden factor: 0.8076677443819104
ROE archetype: Low Return
DuPont ROE decomposition for CINELINE.NS (quarterly period ending 2025-12-31)
Net margin: 9.243412389127707%
EBIT margin: 14.672564975887461%
Interest burden factor: 0.9040442966087944
Tax burden factor: 0.696845624032486
ROE archetype: Standard Business
DuPont ROE decomposition for CINELINE.NS (quarterly period ending 2026-03-31)
ROE: 2.140651854185686%
Net margin: 5.3281994748294155%
Asset turnover: 0.18474077764183966
Equity multiplier (leverage): 2.174717246205953
EBIT margin: 9.001983049267686%
Interest burden factor: 0.61727689808451
Tax burden factor: 0.958875585632483
ROE archetype: Low Return
DuPont ROE decomposition for CIO.V (annual period ending 2021-06-30)
ROE: -15.391914583101626%
Asset turnover: 0
Equity multiplier (leverage): 1.30654271523089
ROE archetype: Low Return
DuPont ROE decomposition for CIO.V (annual period ending 2022-06-30)
ROE: 39.12651808278521%
Asset turnover: 0
Equity multiplier (leverage): 1.2441976735144304
Interest burden factor: 0.988272878381343
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIO.V (annual period ending 2023-06-30)
ROE: -29.0528477763626%
Net margin: -1051.339233555322%
Asset turnover: 0.01837887374486271
Equity multiplier (leverage): 1.5035813931192599
EBIT margin: -461.6587802313354%
ROE archetype: Low Return
DuPont ROE decomposition for CIO.V (annual period ending 2024-06-30)
ROE: -40.126764385793294%
Net margin: -1561.2261146496814%
Asset turnover: 0.010498961360896607
Equity multiplier (leverage): 2.4480596592867414
EBIT margin: -1040.090991810737%
ROE archetype: Low Return
DuPont ROE decomposition for CIZ.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 6
ROE archetype: Standard Business
DuPont ROE decomposition for CL (annual period ending 2022-12-31)
ROE: 244.04466501240694%
Net margin: 10.947848833973396%
Asset turnover: 1.1421397241116267
Equity multiplier (leverage): 19.517369727047146
EBIT margin: 20.13135192296989%
Interest burden factor: 0.7354160906828864
Tax burden factor: 0.7394736842105263
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CL (annual period ending 2023-12-31)
ROE: 278.50255246738516%
Net margin: 12.617566942488564%
Asset turnover: 1.211368447266841
Equity multiplier (leverage): 18.221213840045376
EBIT margin: 20.995014647684638%
Interest burden factor: 0.8303549571603427
Tax burden factor: 0.7237617924528302
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CL (annual period ending 2024-12-31)
ROE: 406.26249167221846%
Net margin: 15.168399582110343%
Asset turnover: 1.2393107062486513
Equity multiplier (leverage): 21.611592271818786
EBIT margin: 21.54121685488284%
Interest burden factor: 0.9136258660508083
Tax burden factor: 0.7707280080889788
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CL (annual period ending 2025-12-31)
ROE: 497.46974697469744%
Net margin: 11.093121381611226%
Asset turnover: 1.2590808005930318
Equity multiplier (leverage): 35.617161716171616
EBIT margin: 20.768324992640565%
Interest burden factor: 0.7226553271911174
Tax burden factor: 0.7391304347826086
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CLM.V (quarterly period ending 2024-12-31)
ROE: 19.83101513972583%
Asset turnover: 0
Equity multiplier (leverage): 1.3147574936625945
Interest burden factor: 1.0843909811797345
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CLM.V (quarterly period ending 2025-03-31)
ROE: -45.53529676131095%
Asset turnover: 0
Equity multiplier (leverage): 1.3904836131322498
ROE archetype: Low Return
DuPont ROE decomposition for CLM.V (quarterly period ending 2025-06-30)
ROE: -111.56610143744257%
Asset turnover: 0
Equity multiplier (leverage): 1.7018531564752097
ROE archetype: Low Return
DuPont ROE decomposition for CLM.V (quarterly period ending 2025-09-30)
ROE: -168.84370655322383%
Asset turnover: 0
Equity multiplier (leverage): 2.694338828151489
ROE archetype: Low Return
DuPont ROE decomposition for CLM.V (quarterly period ending 2025-12-31)
ROE: -45.833329142253994%
Asset turnover: 0
Equity multiplier (leverage): 1.1521350523534164
ROE archetype: Low Return
DuPont ROE decomposition for CLM.V (quarterly period ending 2026-03-31)
ROE: -15.899215519698313%
Asset turnover: 0
Equity multiplier (leverage): 1.2032269474662658
ROE archetype: Low Return
DuPont ROE decomposition for CLON.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.701551341143101
ROE archetype: Standard Business
DuPont ROE decomposition for CLON.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.9763905704046527
ROE archetype: Standard Business
DuPont ROE decomposition for CLON.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 4.061330495918354
ROE archetype: Standard Business
DuPont ROE decomposition for CLU.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.0037783375314864
ROE archetype: Standard Business
DuPont ROE decomposition for CLW.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.5109786973180077
ROE archetype: Standard Business
DuPont ROE decomposition for CM.TO (quarterly period ending 2025-04-30)
ROE: 3.2399186388144527%
Net margin: 28.728886344116805%
Asset turnover: 0.006408333585593817
Equity multiplier (leverage): 17.59827914635328
Tax burden factor: 0.7725173210161663
ROE archetype: Low Return
DuPont ROE decomposition for CM.TO (quarterly period ending 2025-07-31)
ROE: 3.3583823364471006%
Net margin: 29.010380622837367%
Asset turnover: 0.006590956569017122
Equity multiplier (leverage): 17.56419541426992
Tax burden factor: 0.7708716439867598
ROE archetype: Low Return
DuPont ROE decomposition for CM.TO (quarterly period ending 2025-10-31)
ROE: 3.4009295014807597%
Net margin: 28.874172185430464%
Asset turnover: 0.0067556451945258835
Equity multiplier (leverage): 17.434972032543754
Tax burden factor: 0.7808022922636103
ROE archetype: Low Return
DuPont ROE decomposition for CM.TO (quarterly period ending 2026-01-31)
ROE: 4.854196545187787%
Net margin: 37.25513760365341%
Asset turnover: 0.007531596918816936
Equity multiplier (leverage): 17.29992083968652
Tax burden factor: 0.8854612967723507
ROE archetype: Low Return
DuPont ROE decomposition for CM.TO (quarterly period ending 2026-04-30)
ROE: 3.7193222970619404%
Net margin: 30.947897049591965%
Asset turnover: 0.006896354915903961
Equity multiplier (leverage): 17.426616186783445
Tax burden factor: 0.7698313554028733
ROE archetype: Low Return
DuPont ROE decomposition for CMA.AX (annual period ending 2023-06-30)
Net margin: -55.00000000000001%
EBIT margin: -56.04166666666666%
ROE archetype: Standard Business
DuPont ROE decomposition for CMA.AX (annual period ending 2024-06-30)
Net margin: -48.47605224963715%
EBIT margin: -48.47605224963715%
ROE archetype: Standard Business
DuPont ROE decomposition for CMA.AX (annual period ending 2025-06-30)
ROE: -82.43398392652124%
Net margin: -50.280112044817926%
Asset turnover: 1.3625954198473282
Equity multiplier (leverage): 1.2032146957520093
EBIT margin: -44.95798319327731%
ROE archetype: Low Return
DuPont ROE decomposition for CMB.AX (annual period ending 2022-06-30)
ROE: -400.98307484897066%
Equity multiplier (leverage): 2.3770184156733727
ROE archetype: Low Return
DuPont ROE decomposition for CMB.AX (annual period ending 2024-06-30)
ROE: -537.9916970263165%
Net margin: -313736.43949930463%
Asset turnover: 0.00017715600912154131
Equity multiplier (leverage): 9.67954005680683
EBIT margin: -255131.5716272601%
ROE archetype: Low Return
DuPont ROE decomposition for CMB.AX (annual period ending 2025-06-30)
ROE: -164.72047182083907%
Equity multiplier (leverage): 1.9404899122561259
ROE archetype: Low Return
DuPont ROE decomposition for CMBT.BR (annual period ending 2022-12-31)
ROE: 9.351473338655097%
Net margin: 23.78125332731151%
Asset turnover: 0.21533214430674366
Equity multiplier (leverage): 1.8261499495045932
EBIT margin: 23.22080243930691%
Interest burden factor: 1.0382644449035328
Tax burden factor: 0.9863919827230594
ROE archetype: Standard Business
DuPont ROE decomposition for CMBT.BR (annual period ending 2023-12-31)
ROE: 38.664232217860366%
Net margin: 69.4687266977404%
Asset turnover: 0.3421662110494588
Equity multiplier (leverage): 1.6266081018720127
EBIT margin: 48.35518938538304%
Interest burden factor: 1.4466955100728676
Tax burden factor: 0.9930454286626945
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CMBT.BR (annual period ending 2024-12-31)
ROE: 46.98478645726438%
Net margin: 92.6171448748519%
Asset turnover: 0.24899666034539514
Equity multiplier (leverage): 2.037381443979792
EBIT margin: 39.27504078719824%
Interest burden factor: 2.3632941762663764
Tax burden factor: 0.9978309243951682
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CMBT.BR (annual period ending 2025-12-31)
ROE: 8.735796233975805%
Net margin: 9.645155094593296%
Asset turnover: 0.28088284120636026
Equity multiplier (leverage): 3.224542240119986
EBIT margin: 22.204215883991164%
Interest burden factor: 0.4036519435584148
Tax burden factor: 1.0761349253651382
ROE archetype: Standard Business
DuPont ROE decomposition for CMC.DE (annual period ending 2022-12-31)
ROE: 12.888086148625536%
Net margin: 29.49728718281961%
Asset turnover: 0.034843413736314846
Equity multiplier (leverage): 12.539656965368144
Tax burden factor: 0.8160984274141143
ROE archetype: Standard Business
DuPont ROE decomposition for CMC.DE (annual period ending 2023-12-31)
ROE: 15.979103851921122%
Net margin: 31.9789354122567%
Asset turnover: 0.04109513473832059
Equity multiplier (leverage): 12.159004208252044
Tax burden factor: 0.8042589106018309
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMC.DE (annual period ending 2024-12-31)
ROE: 17.38562907724237%
Net margin: 34.50858421024676%
Asset turnover: 0.0430146097963661
Equity multiplier (leverage): 11.712437336092627
Tax burden factor: 0.7787722592932965
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMC.DE (annual period ending 2025-12-31)
ROE: 16.133575416150546%
Net margin: 31.37142762872085%
Asset turnover: 0.043154525651914626
Equity multiplier (leverage): 11.917083807035107
Tax burden factor: 0.7858392451270748
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMD.AX (annual period ending 2021-06-30)
ROE: -22.4160552917044%
Equity multiplier (leverage): 1.1305688777966576
ROE archetype: Low Return
DuPont ROE decomposition for CMD.AX (annual period ending 2022-06-30)
ROE: -35.33384835371899%
Equity multiplier (leverage): 1.3627158124679424
ROE archetype: Low Return
DuPont ROE decomposition for CMD.AX (annual period ending 2023-06-30)
ROE: -38.964132889657016%
Equity multiplier (leverage): 1.258521031405825
ROE archetype: Low Return
DuPont ROE decomposition for CMD.AX (annual period ending 2024-06-30)
ROE: -50.756792674990535%
Equity multiplier (leverage): 1.0877235746381657
ROE archetype: Low Return
DuPont ROE decomposition for CMPI.L (quarterly period ending 2024-11-30)
Equity multiplier (leverage): 1.0495056731471037
ROE archetype: Standard Business
DuPont ROE decomposition for CMPI.L (quarterly period ending 2025-05-31)
Equity multiplier (leverage): 1.04938414596284
ROE archetype: Standard Business
DuPont ROE decomposition for CMPI.L (quarterly period ending 2025-11-30)
Equity multiplier (leverage): 1.0572426847381529
ROE archetype: Standard Business
DuPont ROE decomposition for CMS (annual period ending 2022-12-31)
ROE: 11.020408163265307%
Net margin: 9.737087017217311%
Asset turnover: 0.2741683411475776
Equity multiplier (leverage): 4.128110599078341
EBIT margin: 14.239181014425315%
Interest burden factor: 0.7369281045751634
Tax burden factor: 0.9279379157427938
ROE archetype: Standard Business
DuPont ROE decomposition for CMS (annual period ending 2023-12-31)
ROE: 11.28498727735369%
Net margin: 11.886893594210669%
Asset turnover: 0.23006012024048098
Equity multiplier (leverage): 4.126590330788804
EBIT margin: 16.550522648083625%
Interest burden factor: 0.7724696356275303
Tax burden factor: 0.929769392033543
ROE archetype: Standard Business
DuPont ROE decomposition for CMS (annual period ending 2024-12-31)
ROE: 11.888816452320276%
Net margin: 13.34664005322688%
Asset turnover: 0.21645520399786858
Equity multiplier (leverage): 4.11527292123511
EBIT margin: 19.78709248170326%
Interest burden factor: 0.7552118359112306
Tax burden factor: 0.8931433659839715
ROE archetype: Standard Business
DuPont ROE decomposition for CMS (annual period ending 2025-12-31)
ROE: 11.604095563139932%
Net margin: 12.542452277784284%
Asset turnover: 0.2251222630864344
Equity multiplier (leverage): 4.109702584105315
EBIT margin: 20.22485068509193%
Interest burden factor: 0.7226404169079328
Tax burden factor: 0.8581730769230769
ROE archetype: Standard Business
DuPont ROE decomposition for CMT (quarterly period ending 2025-03-31)
ROE: 1.456566559687202%
Net margin: 3.5526551336924506%
Asset turnover: 0.27481875388544263
Equity multiplier (leverage): 1.4918697830830103
EBIT margin: 4.620241834426416%
Interest burden factor: 1.0331102500880591
Tax burden factor: 0.7442891237640641
ROE archetype: Low Return
DuPont ROE decomposition for CMT (quarterly period ending 2025-06-30)
ROE: 2.6716424799066374%
Net margin: 5.1136435341183%
Asset turnover: 0.35732275120345425
Equity multiplier (leverage): 1.462134149155716
EBIT margin: 6.58009313595578%
Interest burden factor: 1.0285769083237437
Tax burden factor: 0.7555472683199702
ROE archetype: Low Return
DuPont ROE decomposition for CMT (quarterly period ending 2025-09-30)
ROE: 1.2153233038405382%
Net margin: 3.2121160263540687%
Asset turnover: 0.26584564711020525
Equity multiplier (leverage): 1.4232167542385776
EBIT margin: 4.403183023872679%
Interest burden factor: 1.032258064516129
Tax burden factor: 0.7067018072289156
ROE archetype: Low Return
DuPont ROE decomposition for CMT (quarterly period ending 2025-12-31)
ROE: 1.9662052493789839%
Net margin: 4.128446509634828%
Asset turnover: 0.33351048626246027
Equity multiplier (leverage): 1.4280147577001203
EBIT margin: 4.810048609344243%
Interest burden factor: 1.0370267260579065
Tax burden factor: 0.8276510067114093
ROE archetype: Low Return
DuPont ROE decomposition for CMT (quarterly period ending 2026-03-31)
ROE: 0.3824369769147134%
Net margin: 1.0327228035436902%
Asset turnover: 0.24903396941859623
Equity multiplier (leverage): 1.4870224278742825
EBIT margin: 1.3041325981940153%
Interest burden factor: 1.0405759162303665
Tax burden factor: 0.7610062893081762
ROE archetype: Low Return
DuPont ROE decomposition for CMU.V (annual period ending 2022-01-31)
ROE: 20.677653185820745%
Net margin: 84.82181754813976%
Asset turnover: 0.16014404512780442
Equity multiplier (leverage): 1.5222391189658964
EBIT margin: -12.262127074360237%
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CMU.V (annual period ending 2023-01-31)
ROE: -7.0342257352975555%
Net margin: -19.875996515170655%
Asset turnover: 0.23082807836099464
Equity multiplier (leverage): 1.533199797151755
EBIT margin: -1.8618570333995628%
ROE archetype: Low Return
DuPont ROE decomposition for CMU.V (annual period ending 2024-01-31)
ROE: 139.87098047544575%
Net margin: 2309.352711651644%
Asset turnover: 0.05124807757809657
Equity multiplier (leverage): 1.181842958310003
EBIT margin: -260.6795635061192%
Tax burden factor: 0.8849048972423322
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CMU.V (annual period ending 2025-01-31)
ROE: -3.8971155338725776%
Asset turnover: 0
Equity multiplier (leverage): 1.0765047732891915
ROE archetype: Low Return
DuPont ROE decomposition for CMU.V (annual period ending 2026-01-31)
ROE: -6.221867090536367%
Asset turnover: 0
Equity multiplier (leverage): 1.1897062795978102
ROE archetype: Low Return
DuPont ROE decomposition for CMX.AX (annual period ending 2022-06-30)
ROE: -18.548847952787778%
Equity multiplier (leverage): 1.0280780489052563
ROE archetype: Low Return
DuPont ROE decomposition for CMX.AX (annual period ending 2023-06-30)
ROE: -48.411164714971015%
Equity multiplier (leverage): 1.092710459556791
ROE archetype: Low Return
DuPont ROE decomposition for CMX.AX (annual period ending 2024-06-30)
ROE: -81.01956981930726%
Equity multiplier (leverage): 1.4130104210918883
ROE archetype: Low Return
DuPont ROE decomposition for CMX.AX (annual period ending 2025-06-30)
ROE: -731.2616103363729%
Equity multiplier (leverage): 4.762156540653994
ROE archetype: Low Return
DuPont ROE decomposition for CNA (annual period ending 2022-12-31)
ROE: 7.978474496958353%
Net margin: 5.735430157261795%
Asset turnover: 0.19493442622950818
Equity multiplier (leverage): 7.136172204024334
Tax burden factor: 0.8378378378378378
ROE archetype: Standard Business
DuPont ROE decomposition for CNA (annual period ending 2023-12-31)
ROE: 13.0687056016485%
Net margin: 9.180952380952382%
Asset turnover: 0.20881227577538958
Equity multiplier (leverage): 6.816929667588526
Tax burden factor: 0.7938076416337286
ROE archetype: Standard Business
DuPont ROE decomposition for CNA (annual period ending 2024-12-31)
ROE: 9.39919631480937%
Net margin: 6.850489320665762%
Asset turnover: 0.21339451079624705
Equity multiplier (leverage): 6.429628540625306
Tax burden factor: 0.791907514450867
ROE archetype: Standard Business
DuPont ROE decomposition for CNA (annual period ending 2025-12-31)
ROE: 11.547844944429384%
Net margin: 8.686195881193502%
Asset turnover: 0.21647110751462095
Equity multiplier (leverage): 6.141456582633054
Tax burden factor: 0.7888888888888889
ROE archetype: Standard Business
DuPont ROE decomposition for CNC (quarterly period ending 2025-03-31)
ROE: 4.689674863485492%
Net margin: 2.8185328185328187%
Asset turnover: 0.5355911952575709
Equity multiplier (leverage): 3.1066062314857774
EBIT margin: 3.29043329043329%
Interest burden factor: 1.138200782268579
Tax burden factor: 0.7525773195876289
ROE archetype: Low Return
DuPont ROE decomposition for CNC (quarterly period ending 2025-06-30)
ROE: -0.9113504556752278%
Net margin: -0.5190595379754627%
Asset turnover: 0.5620650488067851
Equity multiplier (leverage): 3.1237887684161234
EBIT margin: -0.8268023470518239%
ROE archetype: Low Return
DuPont ROE decomposition for CNC (quarterly period ending 2025-09-30)
ROE: -27.311668520120268%
Net margin: -13.344737371704568%
Asset turnover: 0.5898552961147185
Equity multiplier (leverage): 3.469706330573747
EBIT margin: -0.4246327228818676%
ROE archetype: Low Return
DuPont ROE decomposition for CNC (quarterly period ending 2025-12-31)
ROE: -5.351365814502201%
Net margin: -2.212166918049271%
Asset turnover: 0.6261253887706663
Equity multiplier (leverage): 3.863540171730194
EBIT margin: -2.4776269482151836%
ROE archetype: Low Return
DuPont ROE decomposition for CNC (quarterly period ending 2026-03-31)
ROE: 7.411682658778827%
Net margin: 3.0854557103956433%
Asset turnover: 0.6325147857803219
Equity multiplier (leverage): 3.79775388981074
EBIT margin: 3.726173314111805%
Interest burden factor: 1.1278882321332617
Tax burden factor: 0.7341591233920914
ROE archetype: Standard Business
DuPont ROE decomposition for CNC.V (annual period ending 2022-10-31)
ROE: -4.658046160242062%
Asset turnover: 0
Equity multiplier (leverage): 1.2144820593043093
ROE archetype: Low Return
DuPont ROE decomposition for CNC.V (annual period ending 2023-10-31)
ROE: -10.2849122494409%
Asset turnover: 0
Equity multiplier (leverage): 1.1911981764253774
ROE archetype: Low Return